Stakeholder perspectives on adjunctive mHealth services during transitions of care for patients with schizophrenia-spectrum disorders.

Stakeholder perspectives on adjunctive mHealth services during transitions of care for patients with schizophrenia-spectrum disorders.
复制标题

DOI:
10.1080/09638237.2022.2069693
复制
发表时间:
2024-04
影响因子:
3.3
通讯作者:
Gaudiano, Brandon A.
Gaudiano, Brandon A.
中科院分区:
医学3区
文献类型:
--
作者:
Moitra, Ethan;Park, Hyun Seon;Guthrie, Kate M.;Johnson, Jennifer E.;Peters, Gloria;Wittler, Ellen;Price, Lawrence H.;Gaudiano, Brandon A.

文献摘要

参考文献

相似文献

A growing body of research focuses on developing and testing interventions that leverage mental health-related mobile health (mHealth) services for patients with schizophrenia and other schizophrenia-spectrum disorders. Yet, most formative research has focused on patient perspectives, with little attention paid to clinical stakeholders. This qualitative study aimed to explore clinical stakeholders’ (i.e., administrative supervisors, support staff, and clinicians) perspectives on what might help or hinder the use of mHealth, particularly when patients transition from inpatient to outpatient care. In-depth individual qualitative interviews were conducted with 18 stakeholders from inpatient and outpatient psychiatric settings. Four key themes were identified: (a) adherence challenges; (b) role of mobile technology in patient care; (c) clinical professionals’ receptiveness to adjunctive mHealth services; and, (d) costs related to implementation of mHealth services. Overall, stakeholders agree with extant data showing that supportive networks are important in facilitating patients’ return to the community following hospitalization. Stakeholders welcome mHealth services but suggest they should be appropriately tailored to the population, both in terms of usability and connection to ongoing traditional treatments. Demonstration of added value will likely facilitate wider implementation of mHealth services in the care of patients with schizophrenia and other schizophrenia-spectrum disorders.
DOI: 10.1016/j.schres.2013.03.024
发表时间: 2013-06
影响因子: 4.5
作者:
Fulford D;Niendam TA;Floyd EG;Carter CS;Mathalon DH;Vinogradov S;Stuart BK;Loewy RL
通讯作者: Loewy RL
DOI: 10.1016/j.schres.2019.10.026
发表时间: 2020-02-01
影响因子: 4.5
作者:
Bell, Imogen H.;Rossell, Susan L.;Thomas, Neil
通讯作者: Thomas, Neil
DOI: 10.1348/014466509x467828
发表时间: 2010-06-01
影响因子: 3.1
作者:
Pijnenborg, G. H. M.;Withaar, F. K.;Evans, J. J.
通讯作者: Evans, J. J.
DOI: 10.1093/schbul/sbu033
发表时间: 2014-11-01
影响因子: 6.6
作者:
Ben-Zeev, Dror;Brenner, Christopher J.;Mueser, Kim T.
通讯作者: Mueser, Kim T.
DOI: 10.1176/appi.ps.51.2.216
发表时间: 2000-02-01
影响因子: 3.8
作者:
Olfson, M;Mechanic, D;Weiden, PJ
通讯作者: Weiden, PJ